Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI116897

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

P Costelli, N Carbó, L Tessitore, G J Bagby, F J Lopez-Soriano, J M Argilés, and F M Baccino

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Costelli, P. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Carbó, N. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Tessitore, L. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Bagby, G. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Lopez-Soriano, F. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Argilés, J. in: JCI | PubMed | Google Scholar

Dipartimento di Medicina ed Oncologia Sperimentale, Università di Torino, Italy.

Find articles by Baccino, F. in: JCI | PubMed | Google Scholar

Published December 1, 1993 - More info

Published in Volume 92, Issue 6 on December 1, 1993
J Clin Invest. 1993;92(6):2783–2789. https://doi.org/10.1172/JCI116897.
© 1993 The American Society for Clinical Investigation
Published December 1, 1993 - Version history
View PDF
Abstract

Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2783
page 2783
icon of scanned page 2784
page 2784
icon of scanned page 2785
page 2785
icon of scanned page 2786
page 2786
icon of scanned page 2787
page 2787
icon of scanned page 2788
page 2788
icon of scanned page 2789
page 2789
Version history
  • Version 1 (December 1, 1993): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts